Company: SNWV
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0001628280-25-025878
Chunk: 0

Company: SANUWAVE Health, Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 4.01
Chunk 0
---
Item 4.01 Changes in Registrant's Certifying Accountant.

On May 12, 2025, Sanuwave Health, Inc., a Nevada corporation (the “ Company”), dismissed CBIZ CPAs P. C. (“ CBIZ CPAs”) as the Company’s independent registered public accounting firm, and notified Baker Tilly US, LLP (“ Baker Tilly”) of its formal decision to engage Baker Tilly to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective beginning with the review of the Company’s condensed consolidated financial statements for the quarter ending June 30, 2025, and subject to completion of Baker Tilly’s client acceptance procedures. The engagement of Baker Tilly was approved by the Audit Committee of the Company’s Board of Directors.

From April 11, 2025, the date of CBIZ CPAs’ engagement as the independent registered public accounting firm of the Company, through May 12, 2025, the date of CBIZ CPAs’ dismissal, there were (a) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and CBIZ CPAs on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of CBIZ CPAs, would have caused CBIZ CPAs to make reference to the subject matter of the disagreements in connection with CBIZ CPAs’ reports on the Company’s financial statements, and (b) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions), except for the material weaknesses in the Company’s internal control over financial reporting due to a lack of (i) internal controls over key accounting and IT processes, (ii) expertise and resources to analyze and properly apply U. S. GAAP to complex and non-routine transactions and (iii) internal resources to analyze and properly apply U. S. GAAP to account for financial instruments included in service agreements with select vendors, as previously disclosed under Part I, Item 4 of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.

During the years ended December 31, 2024 and 2023, and the subsequent interim period through the date of this Current Report on Form 8-K, neither the Company nor anyone acting on its